Prostate cancer screening and informed decision-making: Provider and patient perspectives

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 2, 2011, Pages 155-161

  Bowen, D J ^a   Hannon, P A ^b   Harris, J R ^b   Martin, D P ^c  

^a BOSTON UNIVERSITY   (United States)

^b Center for Health Promotion   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

decision making; primary provider; prostate screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; HEALTH BEHAVIOR; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INFORMED DECISION MAKING; MALE; MARRIAGE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROSTATE CANCER; RISK BENEFIT ANALYSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; EARLY DETECTION OF CANCER; GENERAL PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; WASHINGTON;

EID: 79956123247     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.55     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006; 56: 11-25; quiz 49-50 (Pubitemid 43228384)
3. Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the US preventive services task force. Ann Intern Med 2008; 149: 192-199
4. Summaries for patients. Screening for prostate cancer: a recommendation from the US preventive services task force. Ann Intern Med 2002; 137: I48
5. Lim LS, Sherin K. Screening for prostate cancer in US men ACPM position statement on preventive practice. Am J Prev Med 2008; 34: 164-170
6. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park) 2000; 14: 267-272, 77-8, 80 passim
7. Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004; 26: 67-80 (Pubitemid 38045176)
8. Bowen DJ, Allen JD, Vu T, Johnson RE, Fryer-Edwards K, Hart Jr A. Theoretical foundations for interventions designed to promote informed decision making for cancer screening. Ann Behav Med 2006; 32: 202-210 (Pubitemid 44906933)
9. Mullen PD, Allen JD, Glanz K, Fernandez ME, Bowen DJ, Pruitt SL et al. Measures used in studies of informed decision making about cancer screening: a systematic review. Ann Behav Med 2006; 32: 188-201 (Pubitemid 44906932)
10. Woods VD, Montgomery SB, Herring RP, Gardner RW, Stokols D. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc 2006; 98: 492-504
11. Wray RJ, McClure S, Vijaykumar S, Smith C, Ivy A, Jupka K et al. Changing the conversation about prostate cancer among African Americans: results of formative research. Ethn Health 2009; 14: 27-43
12. Halbert CH, Wrenn G, Weathers B, Delmoor E, Ten Have T, Coyne JC. Sociocultural determinants of men's reactions to prostate cancer diagnosis. Psychooncology 2010; 19: 553-560
13. Konety BR, Raut H, Smith BJ, Sharp VJ, Williams RD. Effect of uniform consensus recommendations for PCa screening in older population: differential effects and perceptions of healthcare providers and patients. Urology 2009; 73: 603-608; discussion 8-9
14. Centers for Disease Control and Prevention.. Behavioral Risk Factor Surveillance System. 2010; [updated 6 November 2010; cited 06 November 2010]; Available from: http://www.cdc.gov/ brfss/
15. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc 1998; 280: 1690-1691 (Pubitemid 28532993)
16. Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR. Physician-patient discussions of controversial cancer screening tests. Am J Prev Med 2001; 20: 130-134 (Pubitemid 32106948)
17. Guerra CE, Jacobs SE, Holmes JH, Shea JA. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 2007; 22: 901-907 (Pubitemid 46878594)
18. Hoffman KE, Nguyen PL, Ng AK, D'Amico AV. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. J Urol 2010; 183: 1798-1802